Trade Mark Journal No.2026/042 16 October 2026
WO0000001929775 (44)
Office of origin: United States of America
Date of International Registration:9 June 2026
Date of designation in the UK:
9 June 2026

International priority date claimed: 9 December 2025
(United States of America)
(99538764)
- Class 44
- Medical testing services; medical testing of tumor tissue; immune response testing for medical diagnostic or treatment purposes; testing of tumor tissue response to immune-oncology drugs for the purpose of guiding medical treatment decisions.
ELEPHAS BIOSCIENCES CORPORATION
Representative: David W. Staple Casimir Jones, S.C., 2275 Deming Way, Ste 310, Middleton WI 53562, UNITED STATES OF AMERICA